Receive all Cointelegraph news immediately in Telegram.
Nimirum is a completely decentralized forum platform powered by blockchain technology.
Nimirum is a completely decentralized forum platform powered by blockchain technology. We will be creating an autonomous system with no moderators or admins where everyone is equal. Studies from freedomhouse.org show censorship on the internet has increased as of 2015. For that reason, a platform like nimirum is vital for the good of the internet.
Since the platform is powered by blockchain tech, there will be 100% uptime. If you post something on the Nimirum platform, the post is there to stay.
The platform is planned be released in Q4 of 2016.
We will be raising funds for development of the project through our ICO. The ICO is starting on August 9th, 2016 and will end 30 days later on September 8th, 2016.
Our ICO has a referral program which offers a 7.5% referral bonus. For example, if you refer someone who purchases 1 BTC worth of Nimirum Tokens, you will be rewarded with 0.075 BTC. Referral cookies expire after 1 Month.
Early investors get a bonus:
After the third week no bonuses will be rewarded.
Company name: nimirumCompany site: https://nimirum.org/Company contacts: email@example.com
Follow us on Facebook
This is a paid press release. Cointelegraph does not endorse and is not responsible for or liable for any content, accuracy, quality, advertising, products or other materials on this page. Readers should do their own research before taking any actions related to the company. Cointelegraph is not responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or services mentioned in the press release.
For updates and exclusive offers, enter your e-mail below.
Thank you for contacting us! We will reply to you as soon as possible.
Thank you for your interest in our franchise program.
We are considering your request and will contact you in due course. If you have any further queries, please contact: